NCT02336503 - A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis | Biotech Hunter

Enrollment

189

Participants

Timeline

Start Date

March 10, 2015

Primary Completion Date

November 5, 2015

Study Completion Date

November 5, 2015

Conditions

Hyperhidrosis

Interventions

DRUG

BBI-4000 Gel, 5%

DRUG

BBI-4000 Gel, 10%

DRUG

BBI-4000 Gel, 15%

DRUG

Vehicle

Placebo, BBI-4000 Gel, 0%

Trial Locations (12)

Virginia Clinical Research, Inc., Norfolk

International Clinical Research, Sanford

International Dermatology Research, Inc., Miami

Center for Clinical and Cosmetic Research, Aventura

Shideler Clinical Research Center, Carmel

The Indiana Clinical Trials Center, Plainfield

Minnesota Clinical Study Center, Fridley

Saint Louis University Dermatology, St Louis

The Center for Skin Research, Houston

Academic Dermatology Associates, Albuquerque

Therapeutics Clinical Research, San Diego

Center for Dermatology Clinical Research, Inc., Fremont